Skip to content

Efficacy of Homoeopathy in the Treatment of Nasal Allergy in Comparison with Allopathy

Efficacy of Individualized Homoeopathy in the Treatment of Moderate to Severe Allergic Rhinitis in Comparison with Allopathy: A Multicentric, Randomized Controlled Trial - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/059150
Enrollment
144
Registered
2023-10-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

Intervention1: HOMOEOPATHY: Based on the principles of homoeopathy, homoeopathic medicines in centesimal potencies will be prescribed. Active intervention will be for a period of initial 3 months foll

Sponsors

Central Council for Research in Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with a history of an allergic cause and one or more of the following symptoms: episodic rhinorrhoea, sneezing, obstruction of the nasal passages with lachrymation, post-nasal discharge, and pruritus of the nasal mucosa, conjunctiva and oropharynx together with the anterior rhinoscopic findings of pinkish grey pale, boggy mucosa covered with a thin glistening mucous and hypertrophied turbinates. Presence of moderate to severe symptoms as per ARIA classification and TNSS. Voluntary written informed consent.

Exclusion criteria

Exclusion criteria: Patients who are not adequately symptomatic (Mild cases as per ARIA classification and TNSS) or have rhinoscopic findings not consistent with the diagnosis of AR Patients with serious illnesses (known cases of severe renal or hepatic diseases, malignancy, etc.) Patients under any medication for the symptoms of Allergic rhinitis in the past 15 days Cases with other causes of chronic rhinitis or complications of AR like nasal polyposis, bacterial sinusitis, etc., Patients with significant psychological diseases Pregnancy and lactation Patients not ready to give informed consent.

Design outcomes

Primary

MeasureTime frame
Changes in TNSS (Total Nasal Symptom Score) Changes in RCAT (Rhinitis Control Assessment Test)Timepoint: At Baseline and every 3 months

Secondary

MeasureTime frame
Improvement in the quality of life of the patient through RQLQ Changes in rhinoscopy and AEC. No. of exacerbations during 1 year follow-up period between the groups. To evaluate the role of homoeopathic organopathic remedies in the management of acute exacerbations of Allergic rhinitis in the homoeopathic arm. Timepoint: Improvement in the quality of life of the patient through RQLQ every 3 months. Changes in rhinoscopy and AEC at 6 months intervals. No. of exacerbations during 1 year follow-up period between the groups.

Countries

India

Contacts

Public ContactDr Rompicherla GR Kiranmayee

Central Council for Research in Homoeopathy

grkiranmayee85@ccrhindia.nic.in9030185002

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026